ArticleOrphanet journal of rare diseases2021

Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.

A R Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.